Cargando…

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is a deadly infection, and increasing resistance worsens an already bad scenario. In this work, a new nanomedicine antibacterial agent, based on dihydroartemisinin (DHA) and chitosan (CS), has been successfully developed to overcome MTB’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Xiujuan, Cheng, Qi, He, Ping, Zhang, Yan, Jiang, Zhengfang, Zeng, Yali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500176/ https://www.ncbi.nlm.nih.gov/pubmed/34630358 http://dx.doi.org/10.3389/fmicb.2021.735166

Ejemplares similares

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
por: Lai, Li-Yin, et al.
Publicado: (2020)

Development of Oral Sustained Release Rifampicin Loaded Chitosan Nanoparticles by Design of Experiment
por: Patel, Bhavin K., et al.
Publicado: (2013)

Selective Targeting of 4SO(4)-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System
por: Mubin, Nida, et al.
Publicado: (2018)

Transcriptional Approach for Decoding the Mechanism of rpoC Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant Mycobacterium tuberculosis
por: Xu, Zhihong, et al.
Publicado: (2018)

Hypoxic Non-replicating Persistent Mycobacterium tuberculosis Develops Thickened Outer Layer That Helps in Restricting Rifampicin Entry
por: Jakkala, Kishor, et al.
Publicado: (2019)

Multiplex LNA probe-based RAP assay for rapid and highly sensitive detection of rifampicin-resistant Mycobacterium tuberculosis
por: Zhang, Ruiqing, et al.
Publicado: (2023)

Corrigendum: Selective Targeting of 4SO(4)-N-Acetyl-Galactosamine Functionalized Mycobacterium tuberculosis Protein Loaded Chitosan Nanoparticle to Macrophages: Correlation With Activation of Immune System
por: Mubin, Nida, et al.
Publicado: (2021)

Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
por: Patel, Yesha S., et al.
Publicado: (2017)

The Synergistic Effect of Exogenous Glutamine and Rifampicin Against Mycobacterium Persisters
por: Huang, Xue, et al.
Publicado: (2018)

Protective Effect of Rifampicin Loaded by HPMA-PLA Nanopolymer on Macrophages Infected with Mycobacterium Tuberculosis
por: Yang, Guoping, et al.
Publicado: (2022)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3–5 Days From Sputum Collection
por: Rondón, Liliana, et al.
Publicado: (2018)

Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation
por: Chaudhuri, Swarnava, et al.
Publicado: (2018)

Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy
por: Guo, Shengdi, et al.
Publicado: (2020)

Antimycobacterial Effect of Selenium Nanoparticles on Mycobacterium tuberculosis
por: Estevez, Hector, et al.
Publicado: (2020)

Retracted: Protective Effect of Rifampicin Loaded by HPMA-PLA Nanopolymer on Macrophages Infected with Mycobacterium Tuberculosis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
por: Dutta, Noton K., et al.
Publicado: (2015)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Whole genome sequencing data and analysis of a rifampicin-resistant Mycobacterium tuberculosis strain SBH162 from Sabah, Malaysia
por: Jani, Jaeyres, et al.
Publicado: (2019)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

Mycobacterium tuberculosis Cells Surviving in the Continued Presence of Bactericidal Concentrations of Rifampicin in vitro Develop Negatively Charged Thickened Capsular Outer Layer That Restricts Permeability to the Antibiotic
por: Sebastian, Jees, et al.
Publicado: (2020)

Host-pathogen relationship in retreated tuberculosis with major rifampicin resistance–conferring mutations
por: Hang, Nguyen Thi Le, et al.
Publicado: (2023)

Bacterial Load Comparison of the Three Main Lineages of Mycobacterium tuberculosis Complex in West Africa
por: Osei-Wusu, Stephen, et al.
Publicado: (2021)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
por: Bahraminia, F., et al.
Publicado: (2021)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020)

Rv1717 Is a Cell Wall - Associated β-Galactosidase of Mycobacterium tuberculosis That Is Involved in Biofilm Dispersion
por: Bharti, Suman, et al.
Publicado: (2021)

Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
por: Howard, Nicole C., et al.
Publicado: (2018)

Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D
por: Campodónico, Victoria L., et al.
Publicado: (2018)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
por: Gidari, Anna, et al.
Publicado: (2020)

Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients
por: Vemula, Mani H., et al.
Publicado: (2016)

Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections
por: Subramaniam, Santhni, et al.
Publicado: (2019)

Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jnicfbncpoda3h44t5f2ct32a4